|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.00 USD | -2.51% |
|
-5.32% | -37.47% |
| 06-16 | Moderna, Inc. - Special Call | |
| 06-16 | Sixth Street-backed Caris lifts IPO price range, eyes $5.7 billion valuation | RE |
| Capitalization | 10.06B 8.68B 8.16B 7.4B 13.64B 864B 15.39B 95.1B 37.06B 396B 37.73B 36.93B 1,449B | P/E ratio 2025 * |
-2.57x | P/E ratio 2026 * | -3.51x |
|---|---|---|---|---|---|
| Enterprise value | 4.67B 4.03B 3.79B 3.43B 6.33B 401B 7.14B 44.14B 17.2B 184B 17.51B 17.14B 672B | EV / Sales 2025 * |
2.25x | EV / Sales 2026 * | 2.99x |
| Free-Float |
90.48% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Moderna, Inc.
More recommendations
More press releases
More news
| 1 day | -0.67% | ||
| 1 week | -5.32% | ||
| Current month | -2.11% | ||
| 1 month | +9.94% | ||
| 3 months | -24.90% | ||
| 6 months | -37.84% | ||
| Current year | -37.47% |
| 1 week | 25.46 |  | 28.72 |
| 1 month | 25.1 | | 30.3 |
| Current year | 23.15 | | 48.92 |
| 1 year | 23.15 | | 139.92 |
| 3 years | 23.15 | | 217.25 |
| 5 years | 23.15 | | 497.49 |
| 10 years | 11.54 | | 497.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 52 | 2011-02-28 |
James Mock
DFI | Director of Finance/CFO | 48 | 2022-09-05 |
Stephen Hoge
PSD | President | 49 | 2024-10-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Sagan
BRD | Director/Board Member | 66 | 2018-05-31 |
Noubar Afeyan
CHM | Chairman | 61 | 2012-01-31 |
Stéphane Bancel
BRD | Director/Board Member | 52 | 2011-02-28 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.51% | -5.32% | -81.43% | -79.77% | 10.06B | ||
| -0.56% | -2.32% | +19.12% | +15.50% | 49.38B | ||
| +1.50% | +4.55% | -25.15% | -21.21% | 27.55B | ||
| +0.62% | +3.17% | -3.66% | +20.89% | 26.36B | ||
| -1.21% | +3.35% | +14.98% | -20.71% | 12.75B | ||
| +1.01% | +16.00% | +78.88% | - | 12.46B | ||
| +0.95% | +5.70% | -53.07% | -28.48% | 11.68B | ||
| +4.05% | +2.69% | +39.23% | +113.62% | 10.73B | ||
| +0.72% | +4.33% | +8.96% | +1.61% | 10.28B | ||
| +0.92% | +1.51% | -23.59% | +118.07% | 8.65B | ||
| Average | +0.41% | +1.89% | -2.57% | +13.28% | 17.99B | |
| Weighted average by Cap. | +0.29% | +1.33% | +1.11% | +9.50% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.07B 1.79B 1.68B 1.52B 2.81B 178B 3.17B 19.59B 7.63B 81.53B 7.77B 7.61B 298B | 2.4B 2.07B 1.95B 1.76B 3.25B 206B 3.67B 22.68B 8.84B 94.4B 9B 8.81B 346B |
| Net income | -3.9B -3.37B -3.17B -2.87B -5.29B -335B -5.97B -36.91B -14.39B -154B -14.64B -14.33B -562B | -2.88B -2.48B -2.34B -2.12B -3.9B -247B -4.41B -27.23B -10.61B -113B -10.8B -10.57B -415B |
| Net Debt | -5.39B -4.65B -4.37B -3.96B -7.31B -463B -8.25B -50.96B -19.86B -212B -20.22B -19.79B -776B | -2.88B -2.48B -2.33B -2.12B -3.9B -247B -4.4B -27.21B -10.6B -113B -10.79B -10.57B -415B |
More financial data
* Estimated data
Employees
5,800
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-16 | 26.00 $ | -2.51% | 10,666,074 |
| 25-06-13 | 26.67 $ | -2.49% | 7,180,263 |
| 25-06-12 | 27.35 $ | -1.44% | 8,326,399 |
| 25-06-11 | 27.75 $ | +0.25% | 9,232,411 |
| 25-06-10 | 27.68 $ | -1.63% | 7,888,861 |
Delayed Quote Nasdaq, June 16, 2025 at 04:00 pm
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
26.00USD
Average target price
47.59USD
Spread / Average Target
+83.04%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MRNA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition